News & Events


December 21 2017

Resignation of Chief Medical Officer

vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, regrets to announce that Dr Irina Antonijevic (CMO) will return to Boston as a result of a family health issue.

Read on Download PDF